Divovich, Boris – Trademark Portfolio

Entity Type: 01

Divovich, Boris holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SAVOY and VIATON. The owner is based in Santa Monica, CA.

1419 Stanford Street, front house

Santa Monica, CA 90404

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SAVOY
SAVOY
Registered 2021
VIATON
VIATON
Registered 2020
HERBIX
HERBIX
Abandoned 2020

Trademark Classifications

Divovich, Boris's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Divovich, Boris have?

Divovich, Boris has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Divovich, Boris file in?

Divovich, Boris files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 14 (Jewelry). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Divovich, Boris's most well-known trademarks?

Divovich, Boris's registered trademark portfolio includes well-known marks such as SAVOY and VIATON. These are among 2 currently registered trademarks in the portfolio.

What is Divovich, Boris's trademark registration success rate?

Divovich, Boris has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.